Studies with lymphoma cells over-expressing Myc in vitro also revealed that knockdown of AMPK-α1 using shRNA was associated with a hyperactivation of the mTORC1 pathway, which was to be expected since AMPK is known to restrain mTORC1 activity via multiple mechanisms [5]. The gene discussed is PRKAA1; the disease is lymphoma.